FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 107 filers reported holding FLEXION THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $156,000 | -35.5% | 17,435 | -17.0% | 0.00% | -20.0% |
Q4 2020 | $242,000 | +3.0% | 21,011 | -6.9% | 0.01% | 0.0% |
Q3 2020 | $235,000 | -58.6% | 22,579 | -47.6% | 0.01% | -58.3% |
Q2 2020 | $567,000 | -4.4% | 43,118 | +36.1% | 0.01% | -7.7% |
Q3 2018 | $593,000 | -16.1% | 31,688 | +15.9% | 0.01% | -23.5% |
Q2 2018 | $707,000 | +15.3% | 27,334 | 0.0% | 0.02% | +13.3% |
Q1 2018 | $613,000 | -10.4% | 27,334 | 0.0% | 0.02% | -6.2% |
Q4 2017 | $684,000 | +3.5% | 27,334 | 0.0% | 0.02% | +6.7% |
Q3 2017 | $661,000 | +25.9% | 27,334 | +40.2% | 0.02% | +25.0% |
Q1 2017 | $525,000 | +41.5% | 19,491 | 0.0% | 0.01% | +50.0% |
Q4 2016 | $371,000 | -2.6% | 19,491 | 0.0% | 0.01% | -11.1% |
Q3 2016 | $381,000 | +30.5% | 19,491 | 0.0% | 0.01% | +28.6% |
Q2 2016 | $292,000 | +63.1% | 19,491 | 0.0% | 0.01% | +75.0% |
Q1 2016 | $179,000 | -52.4% | 19,491 | 0.0% | 0.00% | -55.6% |
Q4 2015 | $376,000 | +29.7% | 19,491 | 0.0% | 0.01% | +28.6% |
Q3 2015 | $290,000 | -32.1% | 19,491 | 0.0% | 0.01% | -22.2% |
Q2 2015 | $427,000 | – | 19,491 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |